L-citrulline provides a novel strategy for treating chronic pulmonary hypertension in newborn infants

Candice D. Fike, Marshall Summar, Judy L. Aschner

Research output: Contribution to journalReview article

19 Scopus citations

Abstract

Effective therapies are urgently needed for infants with forms of pulmonary hypertension that develop or persist beyond the first week of life. The L-arginine nitric oxide (NO) precursor, L-citrulline, improves NO signalling and ameliorates pulmonary hypertension in newborn animals. In vitro studies demonstrate that manipulating L-citrulline transport alters NO production. Conclusion: Strategies that increase the supply and transport of L-citrulline merit pursuit as novel approaches to managing infants with chronic, progressive pulmonary hypertension.

Original languageEnglish (US)
Pages (from-to)1019-1026
Number of pages8
JournalActa Paediatrica, International Journal of Paediatrics
Volume103
Issue number10
DOIs
StatePublished - Oct 1 2014

Keywords

  • Bronchopulmonary dysplasia
  • Nitric oxide
  • Oxidative stress
  • Premature infants
  • Pulmonary hypertension

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'L-citrulline provides a novel strategy for treating chronic pulmonary hypertension in newborn infants'. Together they form a unique fingerprint.

  • Cite this